| Ticker Details |
|
Bionano Genomics, Inc.
|
| IPO Date: |
September 21, 2018 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$11.6M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 4.46%
|
| Avg Daily Range (30 D): |
$0.04 | 3.13%
|
| Avg Daily Range (90 D): |
$0.04 | 2.70%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.37M |
| Avg Daily Volume (30 D): |
.24M |
| Avg Daily Volume (90 D): |
.24M |
| Trade Size |
| Avg Trade Size (Sh.): |
17 |
| Avg Trade Size (Sh.) (30 D): |
180 |
| Avg Trade Size (Sh.) (90 D): |
174 |
| Institutional Trades |
| Total Institutional Trades: |
870 |
| Avg Institutional Trade: |
$1.76M |
| Avg Institutional Trade (30 D): |
$.7M |
| Avg Institutional Trade (90 D): |
$.7M |
| Avg Institutional Trade Volume: |
M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.59M |
| Avg Closing Trade (30 D): |
$.7M |
| Avg Closing Trade (90 D): |
$.7M |
| Avg Closing Volume: |
.98K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-12.68
|
$-1.59
|
$-1.99
|
|
Diluted EPS
|
$-12.68
|
$-1.59
|
$-1.99
|
|
Revenue
|
$28.72M
|
$7.37M
|
$6.73M
|
|
Gross Profit
|
$13.2M
|
$3.37M
|
$3.48M
|
|
Net Income / Loss
|
$-38.59M
|
$-8.5M
|
$-6.86M
|
|
Operating Income / Loss
|
$-36.74M
|
$-8.54M
|
$-7.8M
|
|
Cost of Revenue
|
$15.52M
|
$4M
|
$3.26M
|
|
Net Cash Flow
|
$-6.13M
|
$-.5M
|
$-.06M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 27, 2025
|
1:60
|
|
Aug 07, 2023
|
1:10
|
|
|
|